SCHEMBL1401993

SCHEMBL1401993

CCOC(=O)O[C@H]1C=CC(n2cnc3c(NC(c4ccc(OC)cc4)c4ccc(OC)cc4)nc(Cl)nc32)C1

nearest known ligand 0.42

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ADORA1 P30542 14/20 0.42
ADORA3 P0DMS8 13/20 0.42
ADORA2A P29274 7/20 0.42
HTR2C P28335 6/20 0.42
HTR2B P41595 6/20 0.42
TMIGD3 P0DMS9 3/20 0.42
TSPO P30536 2/20 0.42
CHRM3 P20309 1/20 0.41
TMEM97 Q5BJF2 1/20 0.41
HRH2 P25021 1/20 0.39
HTR5A P47898 1/20 0.39
CYP2C9 P11712 1/20 0.39
ADORA2B P29275 1/20 0.38
CCNE2 O96020 1/20 0.37
CCNE1 P24864 1/20 0.37
CDK2 P24941 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL242510 1.00 ADORA1 (0.42) ADORA1ADORA3ADORA2AHTR2CHTR2B
SCHEMBL588937 0.83 ADORA3 (0.53) ADORA1ADORA3ADORA2AADORA2B
SCHEMBL240045 0.83 ADORA3 (0.46) ADORA1ADORA3ADORA2AHTR2CHTR2B
SCHEMBL4220375 0.83 ADORA3 (0.46) ADORA1ADORA3ADORA2AHTR2CHTR2B
SCHEMBL14018046 0.81 HTR2C (0.40) ADORA1ADORA3ADORA2AHTR2CHTR2B
SCHEMBL1908715 0.80 HTR2C (0.41) ADORA1ADORA3ADORA2AHTR2CHTR2B
SCHEMBL241618 0.80 LMNA (0.46) ADORA1ADORA3ADORA2AHTR2CHTR2B
SCHEMBL242801 0.78 ADORA1 (0.37) ADORA1ADORA3ADORA2AHTR2CHTR2B
SCHEMBL1412357 0.75 ADORA3 (0.39) ADORA1ADORA3ADORA2AHTR2CHTR2B
SCHEMBL242153 0.74 ADORA2A (0.49) ADORA1ADORA3ADORA2AHTR2CHTR2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2292619-A1 Purine derivatives for use as adenonsin A-2A receptor agonists Novartis AG (CH) 2011-03-09 EP disclosed